SkinBioTherapeutics Financial Overview
SkinBioTherapeutics's market cap is currently £36.88M. The company's EPS TTM is p0.001; its P/E ratio is -43.18; SkinBioTherapeutics is scheduled to report earnings on December 5, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
